OR WAIT null SECS
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
February 02, 2021
Common approaches to analyze elemental impurities for compliance with regulatory requirements are robust but still have some limitations.
Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.
February 01, 2021
Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
January 04, 2021
Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.
January 03, 2021
Biopharma looks to deliver on COVID-19 vaccines and other promising therapies.
Essential bio/pharma employees show hard work and dedication can pay off for patients.
Demand for specific advanced laboratory skills drives creates a positive employment market.
January 02, 2021
Traditional biologic-based testing methods may need an upgrade to properly test newer therapeutic modalities.
December 03, 2020
A novel PTA technology captures more than 95% of the genomes of single cells, providing more uniform, accurate, and reproducible single-cell analysis data.